Hyperfine, Inc. (NASDAQ:HYPR) Receives Consensus Rating of “Hold” from Brokerages

Hyperfine, Inc. (NASDAQ:HYPR) has earned an average rating of “Hold” from the six analysts that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $1.5875.

A number of brokerages recently issued reports on HYPR. Zacks Research upgraded Hyperfine to a “hold” rating in a research report on Thursday, March 19th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a report on Tuesday, April 21st. Lake Street Capital lifted their price target on Hyperfine from $2.00 to $2.50 and gave the company a “buy” rating in a research report on Thursday, March 19th. Finally, BTIG Research began coverage on Hyperfine in a report on Wednesday, April 29th. They set a “buy” rating and a $2.00 price objective for the company.

Insider Activity at Hyperfine

In other news, COO Thomas Teisseyre sold 24,188 shares of the firm’s stock in a transaction on Monday, March 23rd. The shares were sold at an average price of $1.21, for a total transaction of $29,267.48. Following the sale, the chief operating officer owned 354,648 shares in the company, valued at approximately $429,124.08. This trade represents a 6.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Brett Hale sold 24,188 shares of Hyperfine stock in a transaction on Monday, March 23rd. The stock was sold at an average price of $1.21, for a total transaction of $29,267.48. Following the sale, the chief financial officer directly owned 275,812 shares of the company’s stock, valued at $333,732.52. This represents a 8.06% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 26.33% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. EP Wealth Advisors LLC bought a new stake in Hyperfine during the fourth quarter worth about $34,000. Sanctuary Advisors LLC raised its holdings in shares of Hyperfine by 130.9% during the 4th quarter. Sanctuary Advisors LLC now owns 39,938 shares of the company’s stock valued at $39,000 after buying an additional 22,638 shares in the last quarter. Kathmere Capital Management LLC bought a new stake in Hyperfine in the 4th quarter worth approximately $51,000. Millennium Management LLC purchased a new stake in Hyperfine in the fourth quarter worth approximately $55,000. Finally, Cerity Partners LLC purchased a new stake in Hyperfine in the fourth quarter worth approximately $59,000. Institutional investors own 15.03% of the company’s stock.

Hyperfine Trading Up 0.6%

Hyperfine stock opened at $1.69 on Friday. The firm’s 50 day simple moving average is $1.23 and its 200 day simple moving average is $1.14. The firm has a market capitalization of $165.55 million, a PE ratio of -3.84 and a beta of 1.42. Hyperfine has a 1-year low of $0.53 and a 1-year high of $2.22.

Hyperfine (NASDAQ:HYPR) last announced its quarterly earnings results on Wednesday, March 18th. The company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.02. The firm had revenue of $5.29 million during the quarter, compared to the consensus estimate of $5.30 million. Hyperfine had a negative net margin of 262.29% and a negative return on equity of 95.09%. Research analysts forecast that Hyperfine will post -0.34 earnings per share for the current year.

About Hyperfine

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.